Compare AXGN & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AXGN | ACHC |
|---|---|---|
| Founded | N/A | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2013 | 2011 |
| Metric | AXGN | ACHC |
|---|---|---|
| Price | $48.18 | $28.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 15 |
| Target Price | ★ $42.33 | $22.67 |
| AVG Volume (30 Days) | 776.6K | ★ 1.5M |
| Earning Date | 04-28-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $225,208,000.00 | ★ $3,312,769,000.00 |
| Revenue This Year | $20.57 | $5.08 |
| Revenue Next Year | $16.68 | $5.98 |
| P/E Ratio | ★ N/A | $560.70 |
| Revenue Growth | ★ 20.21 | 5.04 |
| 52 Week Low | $15.27 | $11.43 |
| 52 Week High | $52.91 | $35.83 |
| Indicator | AXGN | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.18 | 44.16 |
| Support Level | $29.48 | $26.62 |
| Resistance Level | $52.91 | $30.20 |
| Average True Range (ATR) | 2.30 | 1.50 |
| MACD | -0.40 | -0.13 |
| Stochastic Oscillator | 30.89 | 22.66 |
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.